Chronic Kidney Disease

Higher baseline systolic blood pressure may be a strong risk factor for dementia and cognitive impairment in patients with chronic kidney disease, according to a recently published study. “High blood pressure and cognitive impairment are common in adults with chronic kidney disease,” Seda Babroudi, MD, of the William B. Schwartz Division of Nephrology in Boston, and colleagues wrote. 

The FDA approved Rivfloza to treat primary hyperoxaluria type 1 in patients aged 9 years and older with relatively preserved kidney function, according to a press release.

Conservative kidney management may be a viable treatment for patients with chronic kidney disease, but researchers found not many patients are aware of the therapy. For older adults with comorbidities, “there is increasing evidence for the potential of [conservative kidney management (CKM)] to maintain quality of life without necessarily decreasing life expectancy,” Jennifer S. Scherer, MD, of the NYU Grossman School of Medicine, and colleagues wrote. 

The American Heart Association unveiled a new term to reflect the interplay of several metabolic and renal conditions driving risk for CVD, along with an updated algorithm and guidance for screening, management and collaborative care.

Long-term voclosporin is safe and efficacious for the treatment of lupus nephritis over 3 years, according to data published in Arthritis & Rheumatology.

Healio spoke with Jay B. Wish, MD, about managing anemia in patients on dialysis.

Healio spoke with Jay B. Wish, MD, about unmet needs in the management of anemia.

Healio spoke with Jay B. Wish, MD, about managing anemia in patients on dialysis.

Healio spoke with Jay B. Wish, MD, about treatment approaches in patients with CKD and anemia.

Healio spoke with Jay B. Wish, MD, about managing challenging cases of anemia.